Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Pronostic des enfants développant une GvHD aiguë de grade III-IV après une greffe allogénique de cellules souches hématopoïétiques

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Allogénique - Apparentée

Allogénique - Non apparentée

Allogénique - Haplo-identique

Principal investigator

Giovanna Lucchini

Evaluation of Outcomes following Allogeneic HCT in Pediatric Patients with High-Risk AML

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Type of treatment

Principal investigator

HSCT for Congenital Amegakaryocitic thrombopecytopenia (CAMT)

Closed Survey/Study

Bone marrow failure

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Clémence Aldebert

Greffe de cellules souches hématopoïétiques (HSCT) pour la thrombocytopénie amégacaryocytaire congénitale (CAMT)

Aplasie Médullaire

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Clémence Aldebert

MDS ATG versus Post-Cy in unrelated donors

Retrospective Studies

Myelodysplastic (MDS) or MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type of treatment

Allogeneic - Unrelated

Principal investigator

Yves Chalandon, Marie Robin

ATG vs Post-Cy chez les donneurs non apparentés dans les MDS

Études rétrospectives

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type of treatment

Allogénique - Non apparentée

Principal investigator

Yves Chalandon, Marie Robin

CLL - Projects about PI, ibrutinib and venetoclax

Retrospective Studies

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Olivier Tournilhac, Michel van Gelder

LLC - Projets sur les inhibiteurs de la voie des PI, l'ibrutinib et le venetoclax

Études rétrospectives

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Olivier Tournilhac, Michel van Gelder

Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP)

Non-interventional Prospective Studies

Complications: infectious

Complications: non-infectious

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Martin Schmidt-Hieber

A prospective outcome study on patients with profound combined immune deficiency (p-CID)

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Multi-centre retrospective study to describe the use and outcomes of ECP in combination with new treatment protocols in Acute and Chronic GvHD

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Dr. Olaf Penack

LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Autoimmune Diseases Working Party (ADWP)

Transplant Complications Working Party (TCWP)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Kirill Kirgizov